Submitted URL: http://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastat...
Effective URL: https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastat...
Submission: On April 27 via manual from US — Scanned from IL

Summary

This website contacted 2 IPs in 1 countries across 1 domains to perform 8 HTTP transactions. The main IP is 172.67.160.11, located in United States and belongs to CLOUDFLARENET, US. The main domain is dnarepair-inhibitors.com.
TLS certificate: Issued by GTS CA 1P5 on April 14th 2024. Valid for: 3 months.
This is the only time dnarepair-inhibitors.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
6 172.67.160.11 13335 (CLOUDFLAR...)
8 2
Apex Domain
Subdomains
Transfer
6 dnarepair-inhibitors.com
dnarepair-inhibitors.com
51 KB
8 1
Domain Requested by
6 dnarepair-inhibitors.com dnarepair-inhibitors.com
8 1

This site contains links to these domains. Also see Links.

Domain
en.wikipedia.org
www.selleck.co.jp
www.novatech-usa.com
www.ddw-online.com
wordpress.org
Subject Issuer Validity Valid
dnarepair-inhibitors.com
GTS CA 1P5
2024-04-14 -
2024-07-13
3 months crt.sh

This page contains 1 frames:

Primary Page: https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
Frame ID: CC5D6C6E424A046614B615F5154A55C2
Requests: 8 HTTP requests in this frame

Screenshot

Page Title

Specialized medical Benefits Subsequent Trifluridine/Tipiracil Answer to Patients Using Metastatic Intestines Most cancers Ineligible pertaining to Regorafenib Remedy. – Dna repair inhibitors

Page URL History Show full URLs

  1. http://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-pat... HTTP 307
    https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-pat... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link rel=["']stylesheet["'] [^>]+/wp-(?:content|includes)/
  • /wp-(?:content|includes)/

Page Statistics

8
Requests

75 %
HTTPS

0 %
IPv6

1
Domains

1
Subdomains

2
IPs

1
Countries

51 kB
Transfer

292 kB
Size

0
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/ HTTP 307
    https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/ Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 6
  • https://dnarepair-inhibitors.com/favicon.ico HTTP 0
  • http://dnarepair-inhibitors.com/wp-includes/images/w-logo-blue-white-bg.png

8 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
Redirect Chain
  • http://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
  • https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
42 KB
10 KB
Document
General
Full URL
https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.67.160.11 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / PHP/7.1.33
Resource Hash
705fe2144a185e0c647fe1a429522cf38014e2c134222996a06aaef58ea256b1

Request headers

Accept-Language
he-IL,he;q=0.9;q=0.9
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/89.0.4389.72 Safari/537.36

Response headers

alt-svc
h3=":443"; ma=86400
cf-cache-status
DYNAMIC
cf-ray
87ae6727fc9f1c8b-FRA
content-encoding
br
content-type
text/html; charset=UTF-8
date
Sat, 27 Apr 2024 11:16:54 GMT
link
<http://dnarepair-inhibitors.com/wp-json/>; rel="https://api.w.org/" <http://dnarepair-inhibitors.com/wp-json/wp/v2/posts/10478>; rel="alternate"; type="application/json" <http://dnarepair-inhibitors.com/?p=10478>; rel=shortlink
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=96zKZ6fWfgY1ypqO%2F8xHf8dVM%2BCUFLUIeM6VkwMkTiczam4vhTR6vBeiI9oyISFJRUNItgbuwjogQgfSRO5jeZxdIPyKC9JNaCuIQqZ9%2FhL607%2B2%2Fu9fM1dEgQ9HbzdQ9GUHbF6qlwWePXo%3D"}],"group":"cf-nel","max_age":604800}
server
cloudflare
x-pingback
http://dnarepair-inhibitors.com/xmlrpc.php
x-powered-by
PHP/7.1.33

Redirect headers

Location
https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
Non-Authoritative-Reason
HttpsUpgrades
style.min.css
dnarepair-inhibitors.com/wp-includes/css/dist/block-library/
87 KB
12 KB
Stylesheet
General
Full URL
https://dnarepair-inhibitors.com/wp-includes/css/dist/block-library/style.min.css?ver=6.0.2
Requested by
Host: dnarepair-inhibitors.com
URL: https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.67.160.11 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d7705700d24d5919255576642ad2c28bfc790390b7183a369038ff5c1e814d51

Request headers

Accept-Language
he-IL,he;q=0.9;q=0.9
Referer
https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/89.0.4389.72 Safari/537.36

Response headers

date
Sat, 27 Apr 2024 11:16:55 GMT
content-encoding
br
cf-cache-status
MISS
last-modified
Wed, 14 Sep 2022 05:50:34 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
etag
W/"63216baa-15b64"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=BUXAg%2FEM9VdS733Y3TIKorSbgY%2BsTjWctgss611GPzBEIgsuXiYHnbT4dr0QarzzbJyIi379LmGNoMdxdvOZdn3YmJzB%2FmA1V6FZycRVc%2FK2h1CwqxxDEmhOa6YtUhe9JqpvsxNwhBZf8QQ%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
cache-control
max-age=18000
cf-ray
87ae672f2c891c8b-FRA
alt-svc
h3=":443"; ma=86400
expires
Sat, 27 Apr 2024 16:16:54 GMT
style.css
dnarepair-inhibitors.com/wp-content/themes/twentytwentyone/
153 KB
24 KB
Stylesheet
General
Full URL
https://dnarepair-inhibitors.com/wp-content/themes/twentytwentyone/style.css?ver=1.6
Requested by
Host: dnarepair-inhibitors.com
URL: https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.67.160.11 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4defdebe5b30bad9e4b4d9d239813b8167fb8cf42d8c511e09f5471d2718703f

Request headers

Accept-Language
he-IL,he;q=0.9;q=0.9
Referer
https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/89.0.4389.72 Safari/537.36

Response headers

date
Sat, 27 Apr 2024 11:16:55 GMT
content-encoding
br
cf-cache-status
MISS
last-modified
Wed, 14 Sep 2022 05:50:34 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
etag
W/"63216baa-263d6"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=VD18hwUBJpTGVRlvqGn56%2FXAI2eyba64kqZ04yXNzWXxYCfm8PYh%2FSEoKClmBMZOHaRIB6QT6iId7u%2FgEgxs6DZAX6ZqCoYJd7632OWUp2Xv7VcZh%2FkYieFUk%2F4RNhmfCMIyB8YY6fu10dc%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
cache-control
max-age=18000
cf-ray
87ae672f2c8b1c8b-FRA
alt-svc
h3=":443"; ma=86400
expires
Sat, 27 Apr 2024 16:16:54 GMT
primary-navigation.js
dnarepair-inhibitors.com/wp-content/themes/twentytwentyone/assets/js/
6 KB
2 KB
Script
General
Full URL
https://dnarepair-inhibitors.com/wp-content/themes/twentytwentyone/assets/js/primary-navigation.js?ver=1.6
Requested by
Host: dnarepair-inhibitors.com
URL: https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.67.160.11 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d4ed7a4032810cdd19a02d86de0fe9dd9a8f7a0277671de91baa8e7cf20631f6

Request headers

Accept-Language
he-IL,he;q=0.9;q=0.9
Referer
https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/89.0.4389.72 Safari/537.36

Response headers

date
Sat, 27 Apr 2024 11:16:54 GMT
content-encoding
br
cf-cache-status
MISS
last-modified
Wed, 14 Sep 2022 05:50:34 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
etag
W/"63216baa-179f"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=GKAkfc01UYr9xgWg0o%2BISLyVvClzcuJCgtIRFJBytiD17%2Fj9nf3W8SEppmvsboqd7Tq3WaBMZygweai1nv9LWeyO1wb528J0fFMOf4HnM4uKdoEQNb28whm8JmtS1R5p97%2F90rg%2BudS2Kh4%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
cache-control
max-age=18000
cf-ray
87ae672f2c8d1c8b-FRA
alt-svc
h3=":443"; ma=86400
expires
Sat, 27 Apr 2024 16:16:54 GMT
responsive-embeds.js
dnarepair-inhibitors.com/wp-content/themes/twentytwentyone/assets/js/
1 KB
1004 B
Script
General
Full URL
https://dnarepair-inhibitors.com/wp-content/themes/twentytwentyone/assets/js/responsive-embeds.js?ver=1.6
Requested by
Host: dnarepair-inhibitors.com
URL: https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.67.160.11 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
c84b9432dad75b6cce98abcd62eecccc82cf4e293e92f80678d8d50bd1060cfe

Request headers

Accept-Language
he-IL,he;q=0.9;q=0.9
Referer
https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/89.0.4389.72 Safari/537.36

Response headers

date
Sat, 27 Apr 2024 11:16:54 GMT
content-encoding
br
cf-cache-status
MISS
last-modified
Wed, 14 Sep 2022 05:50:34 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
etag
W/"63216baa-467"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=sfpCuZnCTNnbOD7WGoHJG%2BtSoxyqHzXBVeo5o9ghDuPV5T0LLJU%2FVZlZ7iBNvYew6TTjIvDJkLbrDypOMl3hAChk%2B99a7dO2KyRGK8FVMPaGxVqGfb9H%2BBoMaKFfDmPQG9L8iuLsVlgLPLc%3D"}],"group":"cf-nel","max_age":604800}
content-type
application/javascript
cache-control
max-age=18000
cf-ray
87ae672f2c8f1c8b-FRA
alt-svc
h3=":443"; ma=86400
expires
Sat, 27 Apr 2024 16:16:54 GMT
wp-emoji-release.min.js
dnarepair-inhibitors.com/wp-includes/js/
0
0

print.css
dnarepair-inhibitors.com/wp-content/themes/twentytwentyone/assets/css/
3 KB
2 KB
Stylesheet
General
Full URL
https://dnarepair-inhibitors.com/wp-content/themes/twentytwentyone/assets/css/print.css?ver=1.6
Requested by
Host: dnarepair-inhibitors.com
URL: https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
172.67.160.11 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
3467f3eee5c95a86bb4992918b1368458185bf349949f862e6e3c5954fcd69f9

Request headers

Accept-Language
he-IL,he;q=0.9;q=0.9
Referer
https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/89.0.4389.72 Safari/537.36

Response headers

date
Sat, 27 Apr 2024 11:16:54 GMT
content-encoding
br
cf-cache-status
MISS
last-modified
Wed, 14 Sep 2022 05:50:34 GMT
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
etag
W/"63216baa-b51"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=X7I8Sv3ElJJtIcAw25WjMnKU%2FugWVkd7ysMjL%2B%2Fm4Efzc4cgrR0eixczdeWt8kuA8BZgq047I9YOMOlP7bkT5QOT%2BdKgs2R67Fiw%2BMLU2JkByJoZo73FvHScKZx3zCIds%2Fs%2BigL85OQ7NsI%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/css
cache-control
max-age=18000
cf-ray
87ae672f5cb91c8b-FRA
alt-svc
h3=":443"; ma=86400
expires
Sat, 27 Apr 2024 16:16:54 GMT
w-logo-blue-white-bg.png
dnarepair-inhibitors.com/wp-includes/images/
Redirect Chain
  • https://dnarepair-inhibitors.com/favicon.ico
  • http://dnarepair-inhibitors.com/wp-includes/images/w-logo-blue-white-bg.png
0
0

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
dnarepair-inhibitors.com
URL
http://dnarepair-inhibitors.com/wp-includes/js/wp-emoji-release.min.js?ver=6.0.2
Domain
dnarepair-inhibitors.com
URL
http://dnarepair-inhibitors.com/wp-includes/images/w-logo-blue-white-bg.png

Verdicts & Comments Add Verdict or Comment

6 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| _wpemojiSettings function| twentytwentyoneToggleAriaExpanded function| twentytwentyoneCollapseMenuOnClickOutside function| twentytwentyoneSubmenuPosition function| twentytwentyoneExpandSubMenu function| twentytwentyoneResponsiveEmbeds

0 Cookies

2 Console Messages

Source Level URL
Text
security error URL: https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/(Line 18)
Message:
Mixed Content: The page at 'https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/' was loaded over HTTPS, but requested an insecure script 'http://dnarepair-inhibitors.com/wp-includes/js/wp-emoji-release.min.js?ver=6.0.2'. This request has been blocked; the content must be served over HTTPS.
security error URL: https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/
Message:
Mixed Content: The page at 'https://dnarepair-inhibitors.com/specialized-medical-benefits-subsequent-trifluridine-tipiracil-answer-to-patients-using-metastatic-intestines-most-cancers-ineligible-pertaining-to-regorafenib-remedy/' was loaded over HTTPS, but requested an insecure favicon 'http://dnarepair-inhibitors.com/wp-includes/images/w-logo-blue-white-bg.png'. This request has been blocked; the content must be served over HTTPS.